R. Lirio

发表

Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases

J. Aubrecht, J. Schneider, P. Gulati, 2020, Clinical pharmacology in drug development.

Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY)

B. Sands, L. Peyrin-Biroulet, S. Danese, 2021, Gastroenterology.

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.

B. Sands, L. Peyrin-Biroulet, E. Loftus, 2019, The New England journal of medicine.

Advances in Pediatric Diagnostic Endoscopy: A State-of-the-Art Review

C. Walsh, D. Fishman, J. Khlevner, 2022, JPGN reports.

Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review

M. Luo, L. Ursos, R. Lirio, 2022, Crohn's & colitis 360.

Vedolizumab Immunogenicity With Long‐Term or Interrupted Treatment of Patients With Inflammatory Bowel Disease

T. Wyant, Lili Yang, R. Lirio, 2021, Journal of clinical pharmacology.

Long‐term safety of vedolizumab for inflammatory bowel disease

S. Vermeire, D. Rubin, B. Sands, 2020, Alimentary pharmacology & therapeutics.

Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease

Dawn B. Beaulieu, R. Arsenescu, D. Beaulieu, 2021, Clinical Pharmacokinetics.

OP26 Long-term safety of vedolizumab in ulcerative colitis and Crohn’s disease: final results from the GEMINI LTS study

S. Vermeire, D. Rubin, B. Sands, 2019, Journal of Crohn's & Colitis.

Sa1664 The First Case Report of Esoflip for Dilation of a Pediatric Esophageal Stricture

J. Lightdale, J. O'Dea, R. Lirio, 2015 .

NASPGHAN Capsule Endoscopy Clinical Report.

C. Walsh, J. Lightdale, D. Fishman, 2017, Journal of pediatric gastroenterology and nutrition.

Management of Upper Gastrointestinal Bleeding in Children: Variceal and Nonvariceal.

R. Lirio, Richard A. Lirio, 2016, Gastrointestinal endoscopy clinics of North America.

Bowel Preparation for Pediatric Colonoscopy: Report of the NASPGHAN Endoscopy and Procedures Committee

D. Fishman, P. Mamula, M. Manfredi, 2014, Journal of pediatric gastroenterology and nutrition.

416a – Vedolizumab Shows Superior Efficacy Versus Adalimumab: Results of Varsity—The First Head-To-Head Study of Biologic Therapy for Moderate-To-Severe Ulcerative Colitis

B. Sands, L. Peyrin-Biroulet, E. Loftus, 2019, Gastroenterology.

Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From VARSITY.

B. Sands, L. Peyrin-Biroulet, E. Loftus, 2021, Gastroenterology.

Using supervised machine learning approach to predict treatment outcomes of vedolizumab in ulcerative colitis patients

R. Lirio, Jingjing Chen, K. Kisfalvi, 2021, Journal of biopharmaceutical statistics.

Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study

D. Turner, J. Hyams, S. Kabilan, 2022, Journal of Crohn's & colitis.

OP34 VARSITY: A double-blind, double-dummy, randomised, controlled trial of vedolizumab versus adalimumab in patients with active ulcerative colitis

B. Sands, L. Peyrin-Biroulet, E. Loftus, 2019, Journal of Crohn's and Colitis.

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. Reply.

B. Sands, R. Lirio, S. Schreiber, 2020, The New England journal of medicine.

Response to letter to editor

Jingjing Chen, R. Lirio, K. Kisfalvi, 2022, The American surgeon.

Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis.

B. Sands, B. Feagan, P. Dulai, 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.